These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10347207)

  • 1. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells.
    Middlemas DS; Kihl BK; Zhou J; Zhu X
    J Biol Chem; 1999 Jun; 274(23):16451-60. PubMed ID: 10347207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
    Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents.
    Middlemas DS; Kihl BK; Moody NM
    J Neurooncol; 1999; 45(1):27-36. PubMed ID: 10728907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
    J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
    Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).
    Hua Z; Zhan Y; Zhang S; Dong Y; Jiang M; Tan F; Liu Z; Thiele CJ; Li Z
    Apoptosis; 2018 Aug; 23(7-8):408-419. PubMed ID: 29959561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons.
    Dedoni S; Olianas MC; Ingianni A; Onali P
    J Neurochem; 2012 Jul; 122(1):58-71. PubMed ID: 22533963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
    Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
    Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
    Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
    Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
    Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
    Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
    Scala S; Wosikowski K; Giannakakou P; Valle P; Biedler JL; Spengler BA; Lucarelli E; Bates SE; Thiele CJ
    Cancer Res; 1996 Aug; 56(16):3737-42. PubMed ID: 8706017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of HERG current and herg gene expression during retinoic acid treatment of human neuroblastoma cells: potentiating effects of BDNF.
    Arcangeli A; Rosati B; Crociani O; Cherubini A; Fontana L; Passani B; Wanke E; Olivotto M
    J Neurobiol; 1999 Aug; 40(2):214-25. PubMed ID: 10413451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y.
    Encinas M; Iglesias M; Llecha N; Comella JX
    J Neurochem; 1999 Oct; 73(4):1409-21. PubMed ID: 10501184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF dependence in neuroblastoma.
    Feng X; Jiang H; Baik JC; Edgar C; Eide FF
    J Neurosci Res; 2001 May; 64(4):355-63. PubMed ID: 11340642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro.
    Fryer RH; Kaplan DR; Kromer LF
    Exp Neurol; 1997 Dec; 148(2):616-27. PubMed ID: 9417837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Am80 induces neuronal differentiation via increased tropomyosin-related kinase B expression in a human neuroblastoma SH-SY5Y cell line.
    Shiohira H; Kitaoka A; Enjoji M; Uno T; Nakashima M
    Biomed Res; 2012; 33(5):291-7. PubMed ID: 23124249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group.
    Kaplan DR; Matsumoto K; Lucarelli E; Thiele CJ
    Neuron; 1993 Aug; 11(2):321-31. PubMed ID: 8394722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
    Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
    Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo.
    Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ
    Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
    Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
    J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.